These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26023151)

  • 21. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress toward measles elimination in the People's Republic of China, 2000-2009.
    Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Measles surveillance in Germany. From sentinel to mandatory surveillance].
    Siedler A; Grüber A; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1321-8. PubMed ID: 23990096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological feasibility of measles eradication.
    Bellini WJ; Rota PA
    Virus Res; 2011 Dec; 162(1-2):72-9. PubMed ID: 21963661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles control in Australia. Report of the Measles Control in Australia Workshop, 5 November 1997.
    Forrest JM; Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Mar; 22(3):33-6. PubMed ID: 9557386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress Toward Regional Measles Elimination - Worldwide, 2000-2015.
    Patel MK; Gacic-Dobo M; Strebel PM; Dabbagh A; Mulders MN; Okwo-Bele JM; Dumolard L; Rota PA; Kretsinger K; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(44):1228-1233. PubMed ID: 27832050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress toward measles elimination in the Russian Federation, 2003-2009.
    Onishchenko G; Ezhlova E; Gerasimova A; Tsvirkun O; Shulga S; Lipskaya G; Mamayeva T; Aleshkin V; Tikhonova N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S366-72. PubMed ID: 21666186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of the COVID-19 pandemic on measles surveillance in the World Health Organisation African Region, 2020.
    Masresha B; Luce R; Katsande R; Dosseh A; Tanifum P; Lebo E; Byabamazima C; Kfutwah A
    Pan Afr Med J; 2021; 39():192. PubMed ID: 34603573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global measles elimination efforts: the significance of measles elimination in the United States.
    Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
    J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress towards measles elimination in Bangladesh, 2000–2016.
    Wkly Epidemiol Rec; 2017 Jul; 92(29-30):405-12. PubMed ID: 28737029
    [No Abstract]   [Full Text] [Related]  

  • 34. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The African Region early experience with structures for the verification of measles elimination - a review.
    Masresha B; Luce R; Tanifum P; Lebo E; Dosseh A; Mihigo R
    Pan Afr Med J; 2020; 35(Suppl 1):1. PubMed ID: 32373252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
    O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timely measles surveillance in the Republic of Korea, 2002-2009: impact of sentinel laboratory surveillance.
    Choe YJ; Eom HS; Bae GR; Cho SI
    J Med Virol; 2014 Feb; 86(2):322-8. PubMed ID: 24027198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global measles control and regional elimination, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Dec; 48(49):1124-30. PubMed ID: 10634347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.